Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 113, Issue 2, 2001, Pages 400-406

  Bairey, O ^a,b   Zimra, Y ^a   Shaklai, M ^a   Rabizadeh, E ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiogenesis; Bcl 2; bFGF; Chronic lymphocytic leukaemia; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PROTEIN BCL 2; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LEUKOCYTE COUNT; LYMPHOCYTES; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035018545     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02731.x     Document Type: Article

References (34)

1. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia
2. Expression of Bcl-2 and Bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease
3. The FGF family of growth factors and oncogenes
4. The importance of surface immunoglobulin, mouse rosettes, and CD5 in the immunophenotyping of chronic lymphocytic leukemia and reactive lymphocytosis
5. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
6. Angiogenic growth factors are hematopoietic growth factors and vice versa
7. Biological roles of fibroblast growth factor-2
8. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
9. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
10. Vascular permeability factor, vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
11. Vascular endothelail growth factor
12. What is the evidence that tumors are angiogenesis dependent?
13. Angiogenesis in cancer, vascular, rheumatoid and other disease
14. Vascular endothelial growth factor induces expression of the anti-apoptotic proteins Bcl-2 and A1 in vascular endothelial cells
15. Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia
16. Expression of apoptosis-regulating proteins in chronic lymphocytic leukaemia: Correlation with in vitro and in vivo chemoresponses
17. Chemosensitivity of B cell chronic lymphocytic leukaemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair
18. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delay apoptosis
19. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
20. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX
21. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine
22. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukemia
23. Vascular endothelial growth factor (VEGF) - Mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
24. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-chronic lymphocytic leukemia
25. Clinical staging of chronic lymphocytic leukemia
26. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance
27. Molecular biology of chronic lymphocytic leukemia: Implication for therapy
28. Bcl-2 expression in chronic lymphocytic leukaemia and its correlation with the induction of apoptosis and clinical outcome
29. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
30. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
31. Basic fibroblast growth factor increases expression of the (v (3 integrin complex on human microvascular endothelial cells
32. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship of p53 gene mutation, bcl-2/bax proteins in drug resistance
33. Integrins and cancer
34. Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells